DocuSign, Inc. (NASDAQ:DOCU) Shares Sold by Brighton Jones LLC

Brighton Jones LLC reduced its position in DocuSign, Inc. (NASDAQ:DOCU) by 1.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,259 shares of the company’s stock after selling 244 shares during the quarter. Brighton Jones LLC’s holdings in DocuSign were worth $709,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Massmutual Trust Co. FSB ADV increased its stake in DocuSign by 5,000.0% during the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock worth $27,000 after buying an additional 500 shares during the period. Mather Group LLC. increased its position in shares of DocuSign by 4,338.5% during the second quarter. Mather Group LLC. now owns 577 shares of the company’s stock worth $31,000 after acquiring an additional 564 shares during the period. Register Financial Advisors LLC acquired a new stake in shares of DocuSign in the first quarter valued at $37,000. ICA Group Wealth Management LLC purchased a new position in DocuSign in the fourth quarter valued at $39,000. Finally, nVerses Capital LLC acquired a new position in DocuSign during the 2nd quarter worth $48,000. 77.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at DocuSign

In other DocuSign news, Director Daniel D. Springer sold 287,052 shares of the stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $53.78, for a total transaction of $15,437,656.56. Following the completion of the sale, the director now directly owns 923,445 shares of the company’s stock, valued at approximately $49,662,872.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, Director Daniel D. Springer sold 287,052 shares of the company’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $53.78, for a total transaction of $15,437,656.56. Following the completion of the sale, the director now owns 923,445 shares in the company, valued at $49,662,872.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Daniel D. Springer sold 70,983 shares of the stock in a transaction on Monday, August 5th. The stock was sold at an average price of $49.84, for a total value of $3,537,792.72. Following the sale, the director now directly owns 891,373 shares of the company’s stock, valued at $44,426,030.32. The disclosure for this sale can be found here. Insiders sold a total of 460,864 shares of company stock valued at $24,549,227 in the last ninety days. Insiders own 1.66% of the company’s stock.

DocuSign Price Performance

Shares of DocuSign stock opened at $57.97 on Friday. The firm’s fifty day simple moving average is $55.87 and its 200-day simple moving average is $56.20. DocuSign, Inc. has a 12 month low of $38.11 and a 12 month high of $64.76. The stock has a market capitalization of $11.87 billion, a price-to-earnings ratio of 111.48, a PEG ratio of 5.99 and a beta of 0.93.

DocuSign (NASDAQ:DOCU) last posted its quarterly earnings data on Thursday, September 5th. The company reported $0.97 EPS for the quarter, beating analysts’ consensus estimates of $0.80 by $0.17. DocuSign had a net margin of 34.56% and a return on equity of 16.18%. The company had revenue of $736.03 million for the quarter, compared to analyst estimates of $727.20 million. During the same period in the previous year, the business posted $0.09 earnings per share. DocuSign’s quarterly revenue was up 7.0% on a year-over-year basis. Analysts anticipate that DocuSign, Inc. will post 0.99 earnings per share for the current year.

Wall Street Analysts Forecast Growth

DOCU has been the topic of a number of analyst reports. Wells Fargo & Company increased their price target on DocuSign from $48.00 to $50.00 and gave the company an “underweight” rating in a research report on Friday, September 6th. Piper Sandler reduced their price objective on shares of DocuSign from $65.00 to $60.00 and set a “neutral” rating on the stock in a report on Friday, June 7th. Royal Bank of Canada lifted their price target on DocuSign from $52.00 to $57.00 and gave the stock a “sector perform” rating in a report on Friday, September 6th. Bank of America increased their price objective on DocuSign from $60.00 to $68.00 and gave the company a “neutral” rating in a report on Friday, September 6th. Finally, Morgan Stanley lowered their price target on DocuSign from $65.00 to $62.00 and set an “equal weight” rating for the company in a report on Friday, June 7th. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, DocuSign has an average rating of “Hold” and a consensus target price of $61.45.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.